Our findings in this study exhibit that linagliptin ameliorates Aβ-induced cytotoxicity in human neuroblastoma cells, and a part of this protective effect is mediated through the activation of Wnt1 signaling and control of cellular inflammation. The gene discussed is WNT1; the disease is neuroblastoma.